217 related articles for article (PubMed ID: 30696851)
21. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
[TBL] [Abstract][Full Text] [Related]
22. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
[TBL] [Abstract][Full Text] [Related]
23. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
Lan MS; Wasserfall C; Maclaren NK; Notkins AL
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
Walikonis JE; Lennon VA
Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
[TBL] [Abstract][Full Text] [Related]
25. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands.
Falorni A; Ortqvist E; Persson B; Lernmark A
J Immunol Methods; 1995 Oct; 186(1):89-99. PubMed ID: 7561152
[TBL] [Abstract][Full Text] [Related]
27. Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585).
Teoh KL; Fida S; Rowley MJ; Mackay IR
Autoimmunity; 1998; 28(4):259-66. PubMed ID: 9892508
[TBL] [Abstract][Full Text] [Related]
28. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
[TBL] [Abstract][Full Text] [Related]
29. Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast.
Powell M; Prentice L; Asawa T; Kato R; Sawicka J; Tanaka H; Petersen V; Munkley A; Morgan S; Rees Smith B; Furmaniak J
Clin Chim Acta; 1996 Dec; 256(2):175-88. PubMed ID: 9027428
[TBL] [Abstract][Full Text] [Related]
30. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
Daw K; Powers AC
Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
[TBL] [Abstract][Full Text] [Related]
31. Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type 1 diabetes.
Ankelo M; Westerlund A; Blomberg K; Knip M; Ilonen J; Hinkkanen AE
Clin Chem; 2007 Mar; 53(3):472-9. PubMed ID: 17259239
[TBL] [Abstract][Full Text] [Related]
32. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
Richter W; Shi Y; Baekkeskov S
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
[TBL] [Abstract][Full Text] [Related]
33. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
34. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
35. A highly sensitive immunoassay resistant to autoantibody interference for detection of the diabetes-associated autoantigen glutamic acid decarboxylase 65 in blood and other biological samples.
Waldrop MA; Suckow AT; Hall TR; Hampe CS; Marcovina SM; Chessler SD
Diabetes Technol Ther; 2006 Apr; 8(2):207-18. PubMed ID: 16734550
[TBL] [Abstract][Full Text] [Related]
36. Replacement of methionine-161 with threonine eliminates a major by-product of human glutamate decarboxylase 65-kDa variant expression in Escherichia coli.
Santos J; Antón EA; Buslje CM; Valdez SN; Villanueva AL; Sica M; Iacono R; Maffia P; Poskus E; Ermácora MR
Biotechnol Appl Biochem; 2000 Jun; 31(3):205-12. PubMed ID: 10814590
[TBL] [Abstract][Full Text] [Related]
37. Engineered variants of human glutamic acid decarboxylase (GAD) and autoantibody epitope recognition.
Primo ME; Anton EA; Villanueva AL; Poskus E; Ermácora MR
Clin Immunol; 2003 Jul; 108(1):38-45. PubMed ID: 12865069
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric microsphere-based immunoassay as a novel non-radiometric method for the detection of glutamic acid decarboxylase autoantibodies in type 1 diabetes mellitus.
Guerra LL; Trabucchi A; Faccinetti NI; Iacono RF; Ureta DB; Poskus E; Valdez SN
Analyst; 2014 Jun; 139(12):3017-25. PubMed ID: 24783226
[TBL] [Abstract][Full Text] [Related]
40. Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus.
Faccinetti NI; Guerra LL; Sabljic AV; Bombicino SS; Rovitto BD; Iacono RF; Poskus E; Trabucchi A; Valdez SN
Microb Cell Fact; 2017 Nov; 16(1):196. PubMed ID: 29132366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
